Skip to content

Bioventus BVS Price / sales

Price / sales at other companies

Stryker logo
StrykerSYK
-1.1×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
2.1×-0.8×
Medtronic logo
MedtronicMDT
2.9×-0.4×
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
2.7×-0.7×
Artivion logo
ArtivionAORT
3.8×+1.2×
Globus Medical logo
Globus MedicalGMED
3.8×-0.3×

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Calculated from Bioventus’s reported figures.

Based on the most recent quarter.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's price / sales?
Bioventus (BVS) reported price / sales of 1.1× in Q1 2026.
How has Bioventus's price / sales changed year-over-year?
Bioventus's price / sales increased by 0.1% year-over-year, from 1.1× to 1.1×.
What is the long-term trend for Bioventus's price / sales?
Over 4 years (2021 to 2025), Bioventus's price / sales has grown at a -19.0% compound annual growth rate (CAGR), from 2× to 0.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.